Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4637043
Max Phase: Preclinical
Molecular Formula: C63H77N10O13S+
Molecular Weight: 1214.43
Molecule Type: Unknown
Associated Items:
ID: ALA4637043
Max Phase: Preclinical
Molecular Formula: C63H77N10O13S+
Molecular Weight: 1214.43
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(N)=O
Standard InChI: InChI=1S/C63H76N10O13S/c1-36(2)29-48(60(82)69-47(19-13-14-28-73(4,5)6)58(80)72-51(35-74)56(64)78)70-57(79)37(3)66-59(81)50(31-39-17-11-8-12-18-39)71-61(83)49(30-38-15-9-7-10-16-38)68-54(77)26-27-65-63(87)67-40-20-23-43(46(32-40)62(84)85)55-44-24-21-41(75)33-52(44)86-53-34-42(76)22-25-45(53)55/h7-12,15-18,20-25,32-34,36-37,47-51,74H,13-14,19,26-31,35H2,1-6H3,(H11-,64,65,66,67,68,69,70,71,72,75,76,77,78,79,80,81,82,83,84,85,87)/p+1/t37-,47-,48-,49-,50-,51-/m0/s1
Standard InChI Key: DWHVELUHKZEMNM-CSSHXORXSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1214.43 | Molecular Weight (Monoisotopic): 1213.5387 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Milosevich N, McFarlane J, Gignac MC, Li J, Brown TM, Wilson CR, Devorkin L, Croft CS, Hof R, Paci I, Lum JJ, Hof F.. (2020) Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins., 28 (1): [PMID:31753799] [10.1016/j.bmc.2019.115176] |
Source(1):